Verona Pharma plc - American Depositary Shares (NQ:VRNA)

106.91 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	106.91
Bid (Size)	106.94 (2)
Ask (Size)	106.95 (3)
Prev. Close	106.91
Today's Range	106.91 - 106.91
52wk Range	106.91 - 106.91
Shares Outstanding	480,291,822
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff

February 06, 2026

The life sciences sector has entered 2026 in the midst of a historic transformation, as deal volume and value surged by a staggering 82% over the past year. This "Great Rebound," fueled by a...

Via MarketMinute

The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs

February 02, 2026

As the pharmaceutical industry enters the heart of its Q4 2025 earnings season this February 2, 2026, a clear divide has emerged between the high-flying giants of the metabolic gold rush and those...

Via MarketMinute

Performance

More News

Looking Into Verona Pharma's Recent Short Interest ↗

August 20, 2025

Via Benzinga

Is the Market Bullish or Bearish on Verona Pharma? ↗

July 18, 2025

Via Benzinga

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

Via MarketMinute

New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82% ↗

December 30, 2025

Via The Motley Fool

FNY Investment Advisers Initiated a New Position in Sibanye Stillwater. Is the Stock a Buy? ↗

December 17, 2025

Via The Motley Fool

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

Via MarketMinute

Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗

November 13, 2025

Via Stocktwits

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

Via MarketMinute

Merck Completes Acquisition of Verona Pharma

October 07, 2025

From Merck & Co., Inc.

Via Business Wire

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today ↗

July 31, 2025

Via The Motley Fool

Does This Move Make Merck Stock a Buy? ↗

July 20, 2025

Via The Motley Fool

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, DALN, RGLD on Behalf of Shareholders

July 19, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business ↗

July 17, 2025

Via The Motley Fool

The trading volume of these stocks is deviating from the norm in today's session. ↗

July 16, 2025

Via Chartmill

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders

July 14, 2025

From Halper Sadeh LLC

Via GlobeNewswire

This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

July 14, 2025

Via Benzinga

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

July 12, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Nvidia's $4 Trillion Milestone Lifts Wall Street: What's Moving Markets Wednesday? ↗

July 09, 2025

Via Benzinga

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders

July 09, 2025

From Halper Sadeh LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)

July 09, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

Which stocks are gapping on Wednesday? ↗

July 09, 2025

Via Chartmill

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug ↗

July 09, 2025

Via Benzinga

Frequently Asked Questions

Is Verona Pharma plc - American Depositary Shares publicly traded?

Yes, Verona Pharma plc - American Depositary Shares is publicly traded.

What exchange does Verona Pharma plc - American Depositary Shares trade on?

Verona Pharma plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Verona Pharma plc - American Depositary Shares?

The ticker symbol for Verona Pharma plc - American Depositary Shares is VRNA on the Nasdaq Stock Market

What is the current price of Verona Pharma plc - American Depositary Shares?

The current price of Verona Pharma plc - American Depositary Shares is 106.91

When was Verona Pharma plc - American Depositary Shares last traded?

The last trade of Verona Pharma plc - American Depositary Shares was at 10/06/25 04:00 PM ET

What is the market capitalization of Verona Pharma plc - American Depositary Shares?

The market capitalization of Verona Pharma plc - American Depositary Shares is 51.35B

How many shares of Verona Pharma plc - American Depositary Shares are outstanding?

Verona Pharma plc - American Depositary Shares has 51B shares outstanding.